Vaginal discharge and drugs of ingredients of duloxetine hydrochloride - a phase IV clinical study of FDA data
Vaginal discharge is found among people who take drugs with ingredients of duloxetine hydrochloride, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 186,349 people who have side effects when taking drugs with ingredients of duloxetine hydrochloride from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Cymbalta, Drizalma sprinkle, Duloxetine hydrochloride.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
186,349 people reported to have side effects when taking drugs with ingredients of duloxetine hydrochloride.
Among them, 108 people (0.06%) have Vaginal discharge
What is Vaginal discharge?
Vaginal discharge is found to be associated with 1,610 drugs and 1,087 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of duloxetine hydrochloride when people have Vaginal discharge *:
- < 1 month: 33.33 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 33.33 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Vaginal discharge when taking drugs with ingredients of duloxetine hydrochloride *:
- female: 99.03 %
- male: 0.97 %
Age of people who have Vaginal discharge when taking drugs with ingredients of duloxetine hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 1.23 %
- 20-29: 9.88 %
- 30-39: 6.17 %
- 40-49: 32.1 %
- 50-59: 29.63 %
- 60+: 20.99 %
Conditions people have *:
- Metastases To Bone (cancer spreads to bone): 27 people, 25.00%
- Pain: 25 people, 23.15%
- Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 14 people, 12.96%
- Birth Control: 11 people, 10.19%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 6.48%
- High Blood Pressure: 7 people, 6.48%
- Migraine (headache): 5 people, 4.63%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 2.78%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 2.78%
- Ovarian Cancer (cancer of ovary): 3 people, 2.78%
Other drugs people take *:
- Celebrex: 30 people, 27.78%
- Zometa: 29 people, 26.85%
- Reglan: 29 people, 26.85%
- Aredia: 27 people, 25.00%
- Tagamet: 24 people, 22.22%
- Acetaminophen: 22 people, 20.37%
- Prozac: 21 people, 19.44%
- Nexium: 21 people, 19.44%
- Celexa: 20 people, 18.52%
- Protonix: 19 people, 17.59%
Other side effects people have besides Vaginal discharge *:
- Headache (pain in head): 51 people, 47.22%
- Pain: 49 people, 45.37%
- Fall: 45 people, 41.67%
- Fatigue (feeling of tiredness): 42 people, 38.89%
- Weakness: 39 people, 36.11%
- Swallowing Difficulty: 39 people, 36.11%
- Back Pain: 38 people, 35.19%
- Memory Loss: 37 people, 34.26%
- Constipation: 36 people, 33.33%
- Breathing Difficulty: 35 people, 32.41%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of duloxetine hydrochloride, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on duloxetine hydrochloride. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vaginal Discharge and drugs of ingredients of duloxetine hydrochloride - 12 seconds ago
- Navane and Ativan drug interaction - 20 seconds ago
- Relpax and Arrhythmias - 21 seconds ago
- Saccharomyces Boulardii and Multi-Organ Failure - 23 seconds ago
- Loratadine and Nicoderm Cq drug interaction - 41 seconds ago
- Avelox and Agranulocytosis - 57 seconds ago
- Glucosamine Hcl and Guaifenesin drug interaction - 59 seconds ago
- Depo-Testosterone and Uniphyl drug interaction - a minute ago
- Valtrex and Blood Urine - a minute ago
- Patanol and Klonopin drug interaction - a minute ago